Minor
NNZ-2591 · Phelan-McDermid Syndrome
Trial sites expanded: 6 → 9 locations
Neuren Pharmaceuticals LimitedPhase 3 NCT07593391 Registry history of NCT07593391 on ClinicalTrials.gov (opens the registry)
Updated
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 6 → 9 locations
Neuren Pharmaceuticals LimitedPhase 3 NCT07593391 Registry history of NCT07593391 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07281079 | A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome | Phelan-McDermid Syndrome | Recruiting | 2026-09-28 |
| NCT07593391 | An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome | Phelan-McDermid Syndrome | Recruiting | 2026-09-21 |